Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ESMO Breast 2020 | MONARCH: Chemo-free options for triple-positive metastatic breast cancer

Evandro de Azambuja, MD, PhD, of the Institut Jules Bordet, Brussels, Belgium, discusses how data from the MONARCH study (NCT02107703) is introducing chemotherapy-free treatment for patients with triple-positive metastatic breast cancer. This interview was recorded via an online conference call with The Video Journal of Oncology (VJOncology).

Choose your cookie settings

VJOncology uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.